Average Co-Inventor Count = 8.18
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (17 from 2,405 patents)
2. Merck + Co., Inc. (4 from 4,770 patents)
21 patents:
1. 11433055 - Chromane monobactam compounds for the treatment of bacterial infections
2. 11230543 - Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections
3. 10508108 - Tricyclic compounds as inhibitors of mutant IDH enzymes
4. 10407421 - Bicyclic aryl monobactam compounds and methods of use thereof for the treatment of bacterial infections
5. 10214512 - Factor XIA inhibitors
6. 10123995 - Factor XIa inhibitors
7. 10086000 - Tricyclic compounds as inhibitors of mutant IDH enzymes
8. 10081617 - Factor XIa inhibitors
9. 10011585 - Factor XIa inhibitors
10. 9783530 - Factor Xla inhibitors
11. 9346825 - Fused bicyclic oxazolidinone CETP inhibitor
12. 9221834 - Cyclic amine substituted oxazolidinone CETP inhibitor
13. 9018200 - Substituted piperidinyl compounds useful as GPR119 agonists
14. 9006228 - Substituted cyclopropyl compounds, compositions containing such compounds, and methods of treatment
15. 8957062 - Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment